CYTK – cytokinetics, incorporated (US:NASDAQ)
Stock Stats
News
Cytokinetics (CYTK) had its price target raised by Leerink Partners from $83.00 to $84.00. They now have an "outperform" rating on the stock.
Cytokinetics (CYTK) had its "neutral" rating reaffirmed by Bank of America Corporation.
Cytokinetics (CYTK) had its price target raised by Needham & Company LLC from $84.00 to $85.00. They now have a "buy" rating on the stock.
Cytokinetics (CYTK) had its price target raised by Citizens Jmp from $88.00 to $96.00. They now have a "market outperform" rating on the stock.
Cytokinetics Q4 Earnings Call Highlights [Yahoo! Finance]
Form S-8 CYTOKINETICS INC
Form 10-K CYTOKINETICS INC For: Dec 31
Form 8-K CYTOKINETICS INC For: Feb 24
Form SCHEDULE 13G/A CYTOKINETICS INC Filed by: T. Rowe Price Investment Management, Inc.
Form 8-K CYTOKINETICS INC For: Feb 17
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.